前一日晚间，HashKey已披露配股结果，每股定价6.68港元，全球发售项下共发行2.41亿股股份，每手单位400股。本次募资总额约16.07亿港 元，扣除上市费用后净额约14.79亿港元。 在公开发售阶段，HashKey获393.71倍认购。其中香港发售占10%，国际配售占90%。合共接获约8.86万份有效申请，受理申请数目29791份， 申购一手获配发股份占所申请股份总数的概约百分比为10%。 记者丨黄子潇 编辑丨孙超逸 12月17日，HASHKEY HLDGS （3887.HK)（下称：HashKey）正式在港交所主板上市，摩根大通、国泰君安国际为联席保荐人。 上市首日 表现平淡。 从全日行情来看，HashKey以0.3%高开，开盘阶段多空博弈激烈，在上午9点42分触及日内最高价7.12港元，涨幅6.6%；随后上午10点左右跌 至6.12港元，跌幅达8.4%。随后时间震荡下跌，直至尾盘少许拉升。 截至收盘，HashKey股价收于6.67港元，全天下跌0.15%，全日成交额6.66亿港元，换手率3.58%，振幅14.96%，主力净流出2131万港元。 不 过，其总市值暂时定格为184.44亿港元，超越其竞 ...

Core Insights - Galaxy Digital reported a net profit of $505 million for Q3 2025, with diluted earnings per share of $1.01 and adjusted EBITDA of $629 million, benefiting from record digital asset trading and investment gains [1] Financial Performance - The quarterly digital asset trading volume increased by 140% quarter-over-quarter [1] - The total asset platform size reached $17 billion [1] Strategic Developments - Galaxy launched the GalaxyOne platform aimed at retail investors in the U.S. in October [1] - The company announced a $460 million equity investment from a global large asset management firm [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 PUXING ENERGY LIMITED 普星能量有限公 司 普星能量有限公 司 （於開曼群島註冊成立的有限公司） （股份代號：90） 補充公告 認購HASHKEY HOLDINGS LIMITED股權 茲提述日期為二零二五年七月九日之自願性公告（「該自願性公告」），內容有 關普星能量有限公司（「本公司」，連同其附屬公司統稱「本集團」）認購HashKey Holdings Limited（「HashKey」）股權之事宜。除文義另有所指外，本公告所用詞 彙與該自願性公告所定義者具有相同涵義。董事會謹此向股東及潛在投資者 提供以下補充資料。 有關認購事項之補充資料 HashKey之持股比例： 代價基準 在同意認購事項之認購價前，董事會已委聘獨立估值機構對HashKey每單位A 系列優先股之市場價值進行評估。 該估值乃根據國際估值準則採用市場法進行。收益法被認為不適用，因其需 依賴對估值結果高度敏感之主觀 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 TIMELESS RESOURCES HOLDINGS LIMITED 天時資源控股有限公司 （於香港註冊成立的有限公司） （股份代號：8028） 自願公告 有關與HASHKEY及艾德證券戰略合作之諒解備忘錄 本公告乃由天時資源控股有限公司（「本公司」，連同其附屬公司統稱「本集團」） 自願作出以通知本公司股東及潛在投資者有關本公司最新之業務發展。 戰 略合作 諒 解備 忘錄 董 事 （「董 事 」）會 （「董事會 」）欣然宣佈， 鑒 於 與 （i ）HashKey Token Limited（ 一 間 於 新 加 坡 註 冊 成 立 之 有 限 公 司 ） （ 「 HashKey」 ） ;（ii）艾 德 證 券 期 貨 有 限 公 司 （ 一 間 於 香 港 註 冊 成 立 之 有 限 公 司 ） （ 「 艾德證 券 」 ） ;及 （iii）本 公 司 之 全 資 附 屬 公 司 白 銀 時 代 有 限 ...

Group 1 - The core point of the article is that Huajian Medical (1931.HK) has seen a significant stock price increase, rising over 12% to HKD 10.4, with a year-to-date gain exceeding 470% [1] - The company has signed a global strategic cooperation framework agreement with HashKey Group, a leading digital asset financial services group, to accelerate the implementation of its "Global Enhanced Ethereum (ETH) Treasury" strategy [1] - Ethereum's price has recently surged, surpassing USD 4600 for the first time since December 2021, which is beneficial for Huajian Medical as it has purchased 5190 ETH at an average price of USD 3661 [1]

Core Viewpoint - 华检医疗 has signed a global strategic cooperation framework agreement with HashKey Group to enhance its digital asset services and accelerate the implementation of its "Global Enhanced Ethereum (ETH) Treasury" strategy [1] Group 1: Company Developments - 华检医疗's stock price surged over 20%, reaching a new high of 9.48 HKD during trading, and is currently up 15.05% at 9.02 HKD with a trading volume of 7.94 million HKD [1] - The cooperation aims to provide more efficient, secure, and compliant digital asset services to both parties' global clients [1] Group 2: Strategic Partnership - The framework agreement will leverage HashKey Group's fully licensed compliance ecosystem to offer one-stop digital asset management services [1] - Services include large-scale trading execution and cost optimization for Ethereum (ETH), global market liquidity support, and exploring the integration of crypto asset reserves with real-world assets, particularly in medical innovation intellectual property [1] - This partnership will enable 华检医疗 to manage its Ethereum (ETH) reserves more efficiently, optimize trading costs, and access broader market resources and technical support globally [1]

Group 1 - The core strategy of the company is to launch a "Global Enhanced Ethereum Vault" with a downward protection mechanism, positioning Ethereum (ETH) as a strategic reserve asset [2][5] - The company has entered into a strategic partnership with HashKey Group, which will provide support for large-scale ETH transactions and explore the integration of crypto assets with real-world assets (RWA) [5][10] - The company has invested 149 million HKD to purchase 5,190 ETH and plans to continue increasing its holdings through a dollar-cost averaging strategy, with an approved budget of 880 million HKD [5][10] Group 2 - The "Active Coin Generation" feature is a key highlight of the company's Ethereum Vault strategy, allowing for the tokenization of innovative drug intellectual property (RWA) and trading on the ivd.xyz exchange [8][9] - The ivd.xyz exchange is the first Web3 exchange focused on medical innovation drug RWA, combining centralized and decentralized exchange features to support cross-chain trading [8][9] - The company's downward protection mechanisms include an ATM mechanism, a priority structure, RWA price buyback commitments, and a clinical VC safety net, providing comprehensive protection for investors [9] Group 3 - The Ethereum Vault strategy opens up a potential market capitalization growth space of over 100 billion HKD, drawing parallels with MicroStrategy's Bitcoin strategy, which saw an 80-fold increase in market value [10] - The company’s current market capitalization exceeds 13 billion HKD, indicating significant growth potential compared to MicroStrategy and Metaplanet [10] - The strategy aligns with the Hong Kong Monetary Authority's Ensemble project and China's innovation drug export strategy, aiming to lower financing costs and accelerate technology transfer [11]

Group 1 - The core strategy of the company is to launch a "Global Enhanced Ethereum Vault" with a downward protection mechanism, designating Ethereum (ETH) as a strategic reserve asset [2][6] - The company has entered into a strategic partnership with HashKey Group, which will provide support for large-scale ETH transactions, cost optimization, and liquidity in global markets [6][9] - The company has invested 149 million HKD to purchase 5,190 ETH and plans to continue increasing its holdings through a dollar-cost averaging strategy, with an approved budget of 880 million HKD [6][11] Group 2 - The "Active Coin Generation" feature is a key highlight of the company's Ethereum Vault strategy, allowing for the tokenization of innovative drug intellectual property (RWA) and trading on the ivd.xyz exchange [9][10] - The downward protection mechanism includes various strategies such as ATM mechanisms, priority structures, and price buyback commitments to ensure investor safety [10][11] - The company aims to replicate the success of MicroStrategy and Metaplanet by leveraging its Ethereum holdings to achieve significant market capitalization growth, with a target to exceed 100 billion HKD in two years [11][13] Group 3 - The company's Web3 exchange ecosystem and Ethereum Vault strategy create a new paradigm for financing, circulation, and revenue distribution in innovative drug development [13] - This approach aligns with the Hong Kong Monetary Authority's policy for efficient cross-border asset circulation and supports China's strategy for innovative drug commercialization [13] - The company aims to provide a compliant and transparent Web3 entry point for retail investors and patients, accelerating the availability of critical medications globally [13]

Core Viewpoint - The company has signed a global strategic cooperation framework agreement with HashKey Group to enhance its digital asset services and implement its "Global Enhanced Ethereum (ETH) Treasury" strategy [1] Group 1 - The agreement aims to accelerate the implementation of the company's strategic initiatives in the digital asset space [1] - The collaboration is expected to provide more efficient, secure, and compliant digital asset services to global clients [1]

Core Viewpoint - The company has signed a global strategic cooperation framework agreement with HashKey Group to accelerate the implementation of its "Global Enhanced Ethereum (ETH) Vault" strategy and provide efficient, secure, and compliant digital asset services to global clients [1][2]. Group 1: Strategic Cooperation - The cooperation aims to leverage HashKey Group's fully licensed compliance ecosystem to provide one-stop digital asset management services, including bulk trading execution and cost optimization for Ethereum (ETH) [2][3]. - The partnership will enhance the company's ability to manage Ethereum (ETH) reserves, optimize trading costs, and access broader market resources and technical support globally [2][3]. Group 2: Ethereum (ETH) Trading Execution and Cost Optimization - HashKey Group will provide professional bulk trading execution services for Ethereum (ETH) through its compliant trading platform, ensuring transactions are executed at optimal prices and costs are further optimized through OTC services [3]. Group 3: Global Market Liquidity Support - HashKey Group's global trading platform will support the company's Ethereum (ETH) vault strategy by providing sufficient liquidity and real-time market insights to optimize investment decisions [4]. Group 4: Integration of Crypto Assets and Real Economy Assets - The collaboration will explore the integration of crypto asset reserves with real economy assets, particularly in the field of medical innovation and intellectual property tokenization, enhancing the efficiency of drug development and funding [5]. Group 5: Future Outlook - The company plans to deepen its collaboration with HashKey Group and explore innovative cooperation models to enhance its competitiveness and influence in the global Web3 space [6]. Group 6: Upcoming Event - A signing ceremony and strategic upgrade announcement event will be held on August 11, 2025, in Hong Kong, showcasing the cooperation's value and strategic blueprint [7][8].